Proactiveinvestors United Kingdom RNS press releases https://www.biotech-capital.com Proactiveinvestors United Kingdom RNS press releases RSS feed en Fri, 19 Jul 2019 14:17:09 +0100 http://blogs.law.harvard.edu/tech/rss Genera CMS action@proactiveinvestors.com (Proactiveinvestors) action@proactiveinvestors.com (Proactiveinvestors) <![CDATA[RNS press release - C4X Discovery collaboration with PhoreMost ]]> https://www.biotech-capital.com/companies/rns/14268/LSE20190625070014_14122717 Tue, 25 Jun 2019 07:00:14 +0100 https://www.biotech-capital.com/companies/rns/14268/LSE20190625070014_14122717 <![CDATA[RNS press release - Interim results ]]> https://www.biotech-capital.com/companies/rns/14268/LSE20190430070012_14056337 Tue, 30 Apr 2019 07:00:12 +0100 https://www.biotech-capital.com/companies/rns/14268/LSE20190430070012_14056337 <![CDATA[RNS press release - Notice of Results ]]> https://www.biotech-capital.com/companies/rns/14268/LSE20190318070007_14005030 Mon, 18 Mar 2019 07:00:07 +0000 https://www.biotech-capital.com/companies/rns/14268/LSE20190318070007_14005030 <![CDATA[RNS press release - PDMR Shareholdings ]]> https://www.biotech-capital.com/companies/rns/14268/LSE20190306111946_13992460 Wed, 06 Mar 2019 11:19:46 +0000 https://www.biotech-capital.com/companies/rns/14268/LSE20190306111946_13992460 <![CDATA[RNS press release - Result of AGM ]]> https://www.biotech-capital.com/companies/rns/14268/LSE20190115102807_13935094 Tue, 15 Jan 2019 10:28:07 +0000 https://www.biotech-capital.com/companies/rns/14268/LSE20190115102807_13935094 <![CDATA[RNS press release - C4X Discovery partnership with Horizon Discovery ]]> https://www.biotech-capital.com/companies/rns/14268/LSE20181217070005_13905284 Mon, 17 Dec 2018 07:00:05 +0000 https://www.biotech-capital.com/companies/rns/14268/LSE20181217070005_13905284 <![CDATA[RNS press release - 2018 Annual Report ]]> https://www.biotech-capital.com/companies/rns/14268/LSE20181211114830_13899418 Tue, 11 Dec 2018 11:48:30 +0000 https://www.biotech-capital.com/companies/rns/14268/LSE20181211114830_13899418 <![CDATA[RNS press release - C4X Discovery collaboration with E-Therapeutics ]]> https://www.biotech-capital.com/companies/rns/14268/LSE20181206070012_13893465 Thu, 06 Dec 2018 07:00:12 +0000 https://www.biotech-capital.com/companies/rns/14268/LSE20181206070012_13893465 <![CDATA[RNS press release - Discovery partnership with GTN Ltd. ]]> https://www.biotech-capital.com/companies/rns/14268/LSE20181129070003_13884330 Thu, 29 Nov 2018 07:00:03 +0000 https://www.biotech-capital.com/companies/rns/14268/LSE20181129070003_13884330 <![CDATA[RNS press release - Discovery partnership with LifeArc ]]> https://www.biotech-capital.com/companies/rns/14268/LSE20181127070012_13881042 Tue, 27 Nov 2018 07:00:12 +0000 https://www.biotech-capital.com/companies/rns/14268/LSE20181127070012_13881042 <![CDATA[RNS press release - Full year results for the year ended 31 July 2018 ]]> https://www.biotech-capital.com/companies/rns/14268/LSE20181121070006_13874334 Wed, 21 Nov 2018 07:00:06 +0000 https://www.biotech-capital.com/companies/rns/14268/LSE20181121070006_13874334 <![CDATA[RNS press release - Notice of Results ]]> https://www.biotech-capital.com/companies/rns/14268/LSE20181109070002_13860991 Fri, 09 Nov 2018 07:00:02 +0000 https://www.biotech-capital.com/companies/rns/14268/LSE20181109070002_13860991 <![CDATA[RNS press release - PDMR Shareholding ]]> https://www.biotech-capital.com/companies/rns/14268/LSE20181022070007_13836495 Mon, 22 Oct 2018 07:00:07 +0100 https://www.biotech-capital.com/companies/rns/14268/LSE20181022070007_13836495 <![CDATA[RNS press release - Exercise of Options and Issue of Equity ]]> https://www.biotech-capital.com/companies/rns/14268/LSE20181019163347_13836276 Fri, 19 Oct 2018 16:33:47 +0100 https://www.biotech-capital.com/companies/rns/14268/LSE20181019163347_13836276 <![CDATA[RNS press release - Grant of Options and Director Dealing ]]> https://www.biotech-capital.com/companies/rns/14268/LSE20181016094557_13830419 Tue, 16 Oct 2018 09:45:57 +0100 https://www.biotech-capital.com/companies/rns/14268/LSE20181016094557_13830419 <![CDATA[RNS press release - Notification of major holdings ]]> https://www.biotech-capital.com/companies/rns/14268/LSE20181010152658_13823962 Wed, 10 Oct 2018 15:26:58 +0100 https://www.biotech-capital.com/companies/rns/14268/LSE20181010152658_13823962 <![CDATA[RNS press release - Notification of major holdings ]]> https://www.biotech-capital.com/companies/rns/14268/LSE20181010152203_13823958 Wed, 10 Oct 2018 15:22:03 +0100 https://www.biotech-capital.com/companies/rns/14268/LSE20181010152203_13823958 <![CDATA[RNS press release - Holdings in Company ]]> https://www.biotech-capital.com/companies/rns/14268/LSE20181010130423_13823661 Wed, 10 Oct 2018 13:04:23 +0100 https://www.biotech-capital.com/companies/rns/14268/LSE20181010130423_13823661 <![CDATA[RNS press release - Holdings in Company ]]> https://www.biotech-capital.com/companies/rns/14268/LSE20181010070005_13822579 Wed, 10 Oct 2018 07:00:05 +0100 https://www.biotech-capital.com/companies/rns/14268/LSE20181010070005_13822579 <![CDATA[RNS press release - Result of General Meeting ]]> https://www.biotech-capital.com/companies/rns/14268/LSE20181005111130_13818435 Fri, 05 Oct 2018 11:11:30 +0100 https://www.biotech-capital.com/companies/rns/14268/LSE20181005111130_13818435